Cian Healthcare Limited
BSE: CHCL
Prev Close
4.15
Open Price
4.15
Volume
4,000
Today Low / High
4.15 / 4.15
52 WK Low / High
2.97 / 4.32
Range
4 - 4
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 4.15, reflecting a change of 0 (0%). The expected target range on the BSE is 4 - 4. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Cian Healthcare Limited Graph
Cian Healthcare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Cian Healthcare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 4.15, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 4.15 | 4.19 | 3.77 - 4.61 |
| 4.23 | 3.39 - 5.08 | ||
| 4.27 | 2.99 - 5.56 | ||
| Bearish Scenario | 4.15 | 4.11 | 3.70 - 4.52 |
| 4.07 | 3.25 - 4.88 | ||
| 4.03 | 2.82 - 5.23 |
Overview of Cian Healthcare Limited
ISIN
INE05BN01019
Industry
Medical - Pharmaceuticals
Vol.Avg
49,423
Market Cap
102,982,696
Last Dividend
0
Official Website
IPO Date
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 61.70 Cr | 30.75 Cr | 30.95 Cr | 0.5017 | 0.00 Cr | 0.00 Cr | 5.40 Cr | 0.25 Cr | 0.10 | 11.31 Cr | 0.0041 |
| 2023-03-31 | 68.59 Cr | 55.25 Cr | 13.34 Cr | 0.1945 | 0.00 Cr | 5.56 Cr | 7.05 Cr | 2.03 Cr | 0.81 | 14.71 Cr | 0.0296 |
| 2022-03-31 | 77.84 Cr | 71.66 Cr | 6.18 Cr | 0.0794 | 0.00 Cr | 5.73 Cr | 0.23 Cr | -5.53 Cr | -2.21 | 7.30 Cr | -0.0711 |
| 2021-03-31 | 73.61 Cr | 60.20 Cr | 13.41 Cr | 0.1821 | 0.00 Cr | 4.59 Cr | 8.44 Cr | 0.05 Cr | 0.02 | 14.30 Cr | 0.0007 |
| 2020-03-31 | 56.92 Cr | 48.22 Cr | 8.70 Cr | 0.1528 | 0.00 Cr | 5.72 Cr | 2.88 Cr | -3.79 Cr | -1.62 | 8.76 Cr | -0.0665 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 1.19 Cr | 161.18 Cr | 103.44 Cr | 57.7405 Cr | 55.69 Cr | 54.50 Cr | 44.16 Cr | 55.05 Cr | 4.20 Cr | 0.00 Cr | 4.89 Cr | 66.1116 Cr |
| 2023-03-31 | 1.33 Cr | 160.48 Cr | 102.99 Cr | 57.4864 Cr | 60.81 Cr | 59.49 Cr | 40.47 Cr | 58.98 Cr | 3.75 Cr | 0.00 Cr | 5.89 Cr | 65.2663 Cr |
| 2022-03-31 | 1.34 Cr | 165.94 Cr | 110.48 Cr | 55.4569 Cr | 63.05 Cr | 61.71 Cr | 42.75 Cr | 66.94 Cr | 7.12 Cr | 0.00 Cr | 5.89 Cr | 69.4528 Cr |
| 2021-03-31 | 2.32 Cr | 157.25 Cr | 99.01 Cr | 58.2439 Cr | 70.73 Cr | 68.41 Cr | 34.70 Cr | 69.13 Cr | 2.47 Cr | 0.00 Cr | 5.89 Cr | 57.7894 Cr |
| 2020-03-31 | 3.45 Cr | 156.54 Cr | 98.35 Cr | 58.1908 Cr | 73.16 Cr | 69.70 Cr | 22.64 Cr | 74.60 Cr | 3.38 Cr | 0.00 Cr | 5.89 Cr | 48.4812 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 6.5430 Cr | -1.5551 Cr | -5.1234 Cr | 5.5645 Cr | -0.1355 Cr | 1.1941 Cr | -0.9786 Cr | 0.2543 Cr | -5.1235 Cr | 0.0000 Cr | -4.2837 Cr |
| 2023-03-31 | -0.1929 Cr | 2.4148 Cr | -2.2339 Cr | -1.5178 Cr | -0.0119 Cr | 1.3296 Cr | -1.3249 Cr | 2.0295 Cr | 0.0000 Cr | 0.0000 Cr | 2.7281 Cr |
| 2022-03-31 | 2.6844 Cr | 1.2352 Cr | -4.9028 Cr | -14.6333 Cr | -0.9832 Cr | 1.3415 Cr | -17.3177 Cr | -5.5335 Cr | -7.6823 Cr | 0.0000 Cr | -8.6466 Cr |
| 2021-03-31 | -1.2241 Cr | 2.5205 Cr | -2.4252 Cr | -2.6953 Cr | -1.1288 Cr | 2.3247 Cr | -1.4712 Cr | 0.0531 Cr | 0.0000 Cr | 0.0000 Cr | -11.0088 Cr |
| 2020-03-31 | -14.1431 Cr | -27.6232 Cr | 42.7976 Cr | -33.7516 Cr | 1.1227 Cr | 3.4535 Cr | -19.6085 Cr | -3.7876 Cr | 8.2004 Cr | 0.0000 Cr | -3.7671 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 18.90 Cr | 20.77 Cr | -1.87 Cr | -0.0990 | -3.86 Cr | -18.25 Cr | -7.30 | -13.41 Cr | -0.9658 |
| 2024-03-31 | 29.08 Cr | 21.59 Cr | 7.50 Cr | 0.2578 | 3.65 Cr | 1.73 Cr | 0.69 | 6.58 Cr | 0.0595 |
| 2023-09-30 | 32.61 Cr | 28.79 Cr | 3.82 Cr | 0.1171 | 1.75 Cr | -1.48 Cr | -0.59 | 4.73 Cr | -0.0453 |
| 2023-03-31 | 37.88 Cr | 32.31 Cr | 5.57 Cr | 0.1470 | 2.77 Cr | 0.48 Cr | 0.20 | 6.02 Cr | 0.0126 |
| 2022-09-30 | 37.88 Cr | 32.31 Cr | 5.57 Cr | 0.1470 | 2.77 Cr | 0.48 Cr | 0.20 | 6.02 Cr | 0.0126 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 1.12 Cr | 0.00 Cr | 1.12 Cr | 18.17 Cr | 28.71 Cr | 56.98 Cr | 51.93 Cr | 144.43 Cr | 104.94 Cr |
| 2024-03-31 | 1.19 Cr | 0.00 Cr | 1.19 Cr | 25.55 Cr | 44.16 Cr | 71.74 Cr | 55.05 Cr | 161.18 Cr | 103.44 Cr |
| 2023-09-30 | 0.86 Cr | 0.00 Cr | 0.86 Cr | 28.27 Cr | 39.10 Cr | 78.74 Cr | 56.26 Cr | 163.12 Cr | 107.11 Cr |
| 2023-03-31 | 1.33 Cr | 0.00 Cr | 1.33 Cr | 31.36 Cr | 40.47 Cr | 74.24 Cr | 58.98 Cr | 160.48 Cr | 102.99 Cr |
| 2022-09-30 | 1.21 Cr | 0.00 Cr | 1.21 Cr | 31.38 Cr | 39.88 Cr | 97.97 Cr | 60.53 Cr | 183.64 Cr | 127.71 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -18.25 Cr | 2.87 Cr | -1.13 Cr | -1.82 Cr | 0.00 Cr | 1.12 Cr | 1.19 Cr | -0.38 Cr | 2.49 Cr |
| 2024-03-31 | 1.73 Cr | 4.49 Cr | -1.75 Cr | -2.41 Cr | 0.33 Cr | 1.19 Cr | 0.86 Cr | -0.46 Cr | 4.03 Cr |
| 2023-09-30 | -1.48 Cr | 2.05 Cr | 0.19 Cr | -2.71 Cr | -0.47 Cr | 0.86 Cr | 1.33 Cr | -0.52 Cr | 1.53 Cr |
| 2023-03-31 | 0.48 Cr | -0.80 Cr | 2.81 Cr | -1.89 Cr | 0.12 Cr | 1.33 Cr | 1.21 Cr | -0.65 Cr | -1.45 Cr |
| 2022-09-30 | 0.48 Cr | 0.61 Cr | -0.39 Cr | -0.34 Cr | -0.13 Cr | 1.21 Cr | 1.34 Cr | -0.67 Cr | -0.06 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹864.00 | ₹103,415,469,120.00 | ₹60,087.00 |
Key Executives
Gender: male
Year Born: 1975
Gender: female
Year Born: 1979
Gender: male
Year Born:
Gender: male
Year Born: 1979
Gender: female
Year Born:
Gender: Not Specified
Year Born: 2000
Gender: male
Year Born: 1970
FAQs about Cian Healthcare Limited
The CEO is Suraj Shriniwas Zanwar.
The current price is ₹4.12.
The range is ₹2.97-4.32.
The market capitalization is ₹10.30 crores.
The P/E ratio is -0.62.
The company operates in the Healthcare sector.
Overview of Cian Healthcare Limited (ISIN: INE05BN01019) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹10.30 crores and an average daily volume of 49,423 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.